| Identification | Back Directory | [Name]
[H]-Lys-Ser-Arg-Ile-Val-Pro-Ala-Ile-Pro-Val-Ser-Leu-Leu-[NH2], Innate defense regulator peptide-1, KSRIVPAIPVSLL-NH2 | [CAS]
940291-10-1 | [Synonyms]
IDR-1
KSRIVPAIPVSLL
Anti-Infective Peptides
Innate Defense-Regulator Peptide
Innate defense regulator peptide-1
IDR-1, Innate Defense-Regulator Peptide
H-Lys-Ser-Arg-Ile-Val-Pro-Ala-Ile-Pro-Val-Ser-Leu-Leu-NH2
(2S)-1-formyl-N-[(2S)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide,propane
[H]-Lys-Ser-Arg-Ile-Val-Pro-Ala-Ile-Pro-Val-Ser-Leu-Leu-[NH2], Innate defense regulator peptide-1, KSRIVPAIPVSLL-NH2
L-Leucinamide, L-lysyl-L-seryl-L-arginyl-L-isoleucyl-L-valyl-L-prolyl-L-alanyl-L-isoleucyl-L-prolyl-L-valyl-L-seryl-L-leucyl- | [Molecular Formula]
C65H118N18O15 | [MDL Number]
MFCD10567316 | [MOL File]
940291-10-1.mol | [Molecular Weight]
1391.74 |
| Hazard Information | Back Directory | [Uses]
IDR-1 is an antimicrobial peptide that is active against Gram-positive and Gram-negative bacteria. IDR-1 counters infection by selective modulation of innate immunity without obvious toxicities. IDR-1 has anti-inflammatory and anti-infective properties, enhances the levels of monocyte chemokines, and attenuates pro-inflammatory cytokine release[1][2]. | [References]
[1] Monisha G Scott, et al. An Anti-Infective Peptide That Selectively Modulates the Innate Immune Response. Nat Biotechnol. 2007 Apr;25(4):465-72. DOI:10.1038/nbt1288
[2] Man Hou, et al. Antimicrobial Peptide LL-37 and IDR-1 Ameliorate MRSA Pneumonia in Vivo. Cell Physiol Biochem. 2013;32(3):614-23. DOI:10.1159/000354465 |
|
|